Showing results (21-30 of 128) with videos related to

Sort By:
Pageof 13
Oncology Reports|September 19, 2018
APOBEC3B is expressed in human glioma, and influences cell proliferation and temozolomide resistanceChristina Schmitt, Ralph Lucius, Michael Synowitz, et al.
Cell Calcium|April 3, 2017
Meprin β and BMP-1 are differentially regulated by CaCl2Janna Schneppenheim, Franka Scharfenberg, Ralph Lucius, et al.
Experimental Eye Research|March 10, 2018
Long-term treatment with anti-VEGF does not induce cell aging in primary retinal pigment epitheliumJohann Schottler, Niklas Randoll, Ralph Lucius, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|November 20, 2009
Sulforaphane suppresses LPS-induced inflammation in primary rat microgliaLars-Ove Brandenburg, Markus Kipp, Ralph Lucius, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 23, 2003
Angiotensin II accelerates functional recovery in the rat sciatic nerve in vivo: role of the AT2 receptor and the transcription factor NF-kappaBKirstin Reinecke, Ralph Lucius, Alexander Reinecke, et al.
Biogerontology|August 16, 2008
Deregulation of versican and elastin binding protein in solar elastosisAnja Knott, Katja Reuschlein, Ralph Lucius, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|July 26, 2014
The retinal pigment epithelium (RPE) induces FasL and reduces iNOS and Cox2 in primary monocytesChristin Hettich, Sebastian Wilker, Rolf Mentlein, et al.
Neurological Research|July 17, 2015
Erythropoietin and CCL3 antagonise their functional properties during neuroinflammationKirsten Hattermann, Friederike Knerlich-Lukoschus, Ralph Lucius, et al.
Molecular Immunology|April 16, 2010
Antimicrobial peptide rCRAMP induced glial cell activation through P2Y receptor signalling pathwaysLars-Ove Brandenburg, Sandra Jansen, Christoph J Wruck, et al.
CNS Drugs|March 13, 2002
Angiotensin AT2 receptor ligands: do they have potential as future treatments for neurological disease?Philip Rosenstiel, Stefan Gallinat, Alexander Arlt, et al.
Pageof 13